Effect of Continuous Intake of Lactobacillus salivarius WB21 on Tissues Surrounding Implants: A Double-Blind Randomized Clinical Trial DOI Creative Commons
Yusuke Taniguchi, Nao Suzuki,

Kae Kakura

и другие.

Life, Год журнала: 2024, Номер 14(12), С. 1532 - 1532

Опубликована: Ноя. 22, 2024

Objective: This study aimed to improve the health of peri-implant tissues through continuous intake Lactobacillus salivarius WB21 (LSWB21) tablets. Methods: A double-blind, randomized controlled trial was conducted with 23 maintenance patients who had generally healthy oral tissues. Participants were divided into a test group (n = 12) receiving LSWB21 tablets and control 11) placebos. All took one tablet three times daily for 2 months. Evaluation measures included modified Gingival Index (mGI), Plaque (mPI), Bleeding (mBI), salivary secretory IgA, symptoms assessed at baseline, 1 month, Results: After months, significant improvements in mGI, mPI, mBI observed group; improvement mPI group. Changes mGI over months significantly differed between groups (p 0.038), multiple regression analysis confirmed effectiveness reducing 0.034). Subjective such as bad breath tongue also improved. Conclusion: Continuous may be beneficial stabilizing tissue. Trial registration: UMIN000039392 (UMIN-CTR).

Язык: Английский

How far does feedback on oral malodor assessment influence the decision to quit smoking? DOI
Omer Waleed Majid

Evidence-Based Dentistry, Год журнала: 2024, Номер 25(2), С. 65 - 66

Опубликована: Фев. 21, 2024

Язык: Английский

Процитировано

0
Effect of Continuous Intake of Lactobacillus salivarius WB21 on Tissues Surrounding Implants: A Double-Blind Randomized Clinical Trial DOI Creative Commons
Yusuke Taniguchi, Nao Suzuki,

Kae Kakura

и другие.

Life, Год журнала: 2024, Номер 14(12), С. 1532 - 1532

Опубликована: Ноя. 22, 2024

Objective: This study aimed to improve the health of peri-implant tissues through continuous intake Lactobacillus salivarius WB21 (LSWB21) tablets. Methods: A double-blind, randomized controlled trial was conducted with 23 maintenance patients who had generally healthy oral tissues. Participants were divided into a test group (n = 12) receiving LSWB21 tablets and control 11) placebos. All took one tablet three times daily for 2 months. Evaluation measures included modified Gingival Index (mGI), Plaque (mPI), Bleeding (mBI), salivary secretory IgA, symptoms assessed at baseline, 1 month, Results: After months, significant improvements in mGI, mPI, mBI observed group; improvement mPI group. Changes mGI over months significantly differed between groups (p 0.038), multiple regression analysis confirmed effectiveness reducing 0.034). Subjective such as bad breath tongue also improved. Conclusion: Continuous may be beneficial stabilizing tissue. Trial registration: UMIN000039392 (UMIN-CTR).

Язык: Английский

Процитировано

0